Patients with Parkinson's Disease (PD) depend on medication for relief of motor symptoms, and for this reason are often assumed to medicate very carefully. Overall, medication adherence is very good, ...
The study is designed to measure the efficacy and safety of levetiracetam on levodopa-induced dyskinesias in late-stage Parkinson's disease. The patients are planned to be treated with levetiracetam ...
This study will test the use of a radioactive substance called [11C]dLop for measuring P-glycoprotein (P-gp) using positron emission tomography (PET) imaging. The P-gp protein acts as a pump' in ...
The purpose of this study is to determine the safety and efficacy of AAV-GAD gene transfer
into the subthalamic nucleus (STN) region of the brain. This study involves the treatment of ...
This study will measure the function of a protein called P-glycoprotein (P-gp), which is
found at the blood-brain barrier, a membrane that normally prevents toxic material from
entering ...
Participants will complete a self-selected intensity of exercising over a 6 month period, with detailed clinical assessments at commencement and completion to determine the rate of progression of ...
Entacapone is an antiparkinsonian drug which block L-dopa metabolism, inhibiting the C-O-methyltransferase (COMT) enzyme. There is an individual variability of the COMT activity determined by a ...
The purpose of this double blind study is to determine whether CERE-120 (adeno-associated virus serotype 2 [AAV2]-neurturin [NTN]) is effective and safe in the treatment of patients with idiopathic ...
To identify patients within the community taking anti-parkinson medications in whom the diagnosis of Parkinson’s disease is incorrect and to supervise and clinically monitor the withdrawal of ...